Feathery Raises $30.0M for

Refr Sports

Refr Sports is assisting the referee industry by providing essential tools for referee assignors to excel. Addressing scheduling challenges and referee shortages, Refr Sports streamlines operations with user-friendly mobile and web applications. These applications enhance transparency, facilitate seamless payments, and simplify scheduling, transaction, networking, and communication processes. By aiding a struggling industry, Refr Sports aims to support over 105 million sports competitions annually in the U.S., offering a scalable and efficient solution for referee management. MN Twins Techstars '23

Wugen

Allotera Therapeutics, Inc., headquartered in St. Louis, Missouri, is a clinical-stage biotechnology company focused on developing next-generation, allogeneic CAR-T cell therapies for cancer. Allotera’s proprietary gene-editing platform is designed to overcome key limitations of first-generation cell therapies, enabling scalable, off-the-shelf treatments with biologics-like cost of goods margins. The lead program, WU‑CART-007, targets CD7 and has demonstrated best-in-class efficacy in T-ALL/T-LBL, with the potential to be the first approved allogeneic CAR-T therapy for T-cell malignancies.